ArticleGland surgery2022
The clinical importance of overweight or obesity on tumor recurrence in papillary thyroid carcinoma.
Article in Gland surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 9 citations in OpenAlex.
- Postoperative serum oxidative stress measures in women with papillary thyroid cancer.Frontiers in endocrinology · 2026Article
- Clinical and morphological predictors of metastasis in papillary thyroid microcarcinoma.Frontiers in endocrinology · 2025Article
- Correlation between body mass index and lymph node metastasis in papillary thyroid carcinoma: a retrospective clinical study.Gland surgery · 2024Article
- Analysis of Body Mass Index and Clinicopathological Factors in Patients with Papillary Thyroid Carcinoma.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024Article
- RELATIONSHIP BETWEEN BODY MASS INDEX AND PATOHISTOLOGICAL FEATURES OF THYROID CANCER.Acta clinica Croatica · 2022Article
- Metastasis of papillary thyroid cancer: does body mass index (BMI) is the key factor?Gland surgery · 2022Article
- Is obesity associated with the prognosis of papillary thyroid carcinoma?Gland surgery · 2022Article
Corrections and comments
- Commented on by
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is known to common, preventable, and modifiable cause of carcinogenesis. Obesity may be associated with the risk and prognosis of papillary thyroid carcinoma (PTC), but the results of studies are controversial. We studied whether overweight or obesity would be associated with poor prognoses, such as tumor recurrence in PTC patients.
methodsPTC patients at a single institution were retrospectively reviewed.
resultsA total of 403 PTC patients (352 women and 51 men; mean age, 48 years) were enrolled. They underwent total thyroidectomy or lobectomy from January 2000 through December 2010. One-hundred forty-eight cases (37%) were categorized as overweight or obese [body mass index (BMI) ≥25 kg/m
conclusionsOverweight or obesity might be associated with poor prognosis factors. However, they might not be associated with tumor recurrences of PTC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.